We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.3B
2
AAL icon
American Airlines Group
AAL
+$853M
3
ISRG icon
Intuitive Surgical
ISRG
+$816M
4
MS icon
Morgan Stanley
MS
+$681M
5
WYNN icon
Wynn Resorts
WYNN
+$622M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.4B
2
EBAY icon
eBay
EBAY
+$763M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$760M
4
AVGO icon
Broadcom
AVGO
+$757M
5
USB icon
US Bancorp
USB
+$686M

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Consumer Discretionary 13.46%
3 Financials 12.79%
4 Industrials 12.13%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHL
1876
DELISTED
Greenhill & Co., Inc.
GHL
$573K ﹤0.01%
11,626
+20
+0.2% +$987
HAE icon
1877
Haemonetics
HAE
$4.11B
$571K ﹤0.01%
16,180
-2,600
-14% -$86.9K
SGMO
1878
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$570K ﹤0.01%
37,300
– –
LABC
1879
DELISTED
LOUISIANA BANCORP INC COM STK NEW (LA)
LABC
$569K ﹤0.01%
28,635
– –
NWBI icon
1880
Northwest Bancshares
NWBI
$2.31B
$568K ﹤0.01%
41,879
+5,400
+15% +$74.1K
OTTR icon
1881
Otter Tail
OTTR
$3.9B
$568K ﹤0.01%
18,750
+1,500
+9% +$43.7K
ESSA
1882
DELISTED
ESSA Bancorp
ESSA
$567K ﹤0.01%
50,900
– –
MXWL
1883
DELISTED
Maxwell Technologies Inc
MXWL
$567K ﹤0.01%
37,500
– –
IRF
1884
DELISTED
INTL RECTIFIER CORP
IRF
$567K ﹤0.01%
20,320
– –
NBTB icon
1885
NBT Bancorp
NBTB
$2.79B
$566K ﹤0.01%
23,580
+1,000
+4% +$23.3K
NGG icon
1886
National Grid
NGG
$81.6B
$565K ﹤0.01%
7,878
– –
NTK
1887
DELISTED
NORTEK INC COM NEW (DE)
NTK
$565K ﹤0.01%
6,300
-500
-7% -$42.3K
FMBI
1888
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$564K ﹤0.01%
33,093
– –
AEL
1889
DELISTED
American Equity Investment Life Holding Company
AEL
$563K ﹤0.01%
22,900
– –
AWR icon
1890
American States Water
AWR
$3.52B
$561K ﹤0.01%
16,896
+529
+3% +$16.2K
SENEB
1891
Seneca Foods Class B
SENEB
$1.33B
$560K ﹤0.01%
17,170
– –
BCE icon
1892
BCE
BCE
$21.7B
$554K ﹤0.01%
+12,200
New +$550K
TTWO icon
1893
Take-Two Interactive
TTWO
$45.2B
$553K ﹤0.01%
24,845
+4,700
+23% +$96.2K
WERN icon
1894
Werner Enterprises
WERN
$2.31B
$553K ﹤0.01%
20,845
-2,217
-10% -$57.4K
BAC.PRL icon
1895
Bank of America Series L
BAC.PRL
$4.01B
$550K ﹤0.01%
471
+74
+19% +$86.2K
CMC icon
1896
Commercial Metals
CMC
$7.98B
$549K ﹤0.01%
31,700
– –
IPXL
1897
DELISTED
Impax Laboratories, Inc.
IPXL
$549K ﹤0.01%
18,300
– –
SKX
1898
DELISTED
Skechers
SKX
$548K ﹤0.01%
36,000
+300
+0.8% +$4.13K
AMCC
1899
DELISTED
Applied Micro Circuits Corporation New
AMCC
$548K ﹤0.01%
50,700
+22,000
+77% +$215K
HRC
1900
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$546K ﹤0.01%
13,150
– –
74 75
76
77 78

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.